Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIT
5076
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $147K | ﹤0.01% |
38,500
+2,700
| +8% | +$10K |
|
|
AKS
5077
CALL
DELISTED
AK Steel Holding Corp
AKS
| $147K | ﹤0.01% |
64,700
+18,000
| +39% | +$43.2K |
|
5078
CALL
Albemarle
ALB
$13.9B
| $146K | ﹤0.01% |
2,100
-2,500
| -54% | -$170K |
|
|
BHR
5079
Braemar Hotels & Resorts
BHR
$156M
| $146K | ﹤0.01% |
15,772
-5,000
| -24% | -$45.4K |
|
5080
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
| $146K | ﹤0.01% |
2,894
-253,253
| -99% | -$12.3M |
|
|
HOLX
5081
CALL
DELISTED
Hologic
HOLX
| $146K | ﹤0.01% |
2,900
+2,100
| +263% | +$103K |
|
5082
Omega Flex
OFLX
$297M
| $146K | ﹤0.01% |
1,429
-1,081
| -43% | -$89.7K |
|
|
TAST
5083
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $146K | ﹤0.01% |
17,621
-13,098
| -43% | -$110K |
|
5084
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $145K | ﹤0.01% |
5,234
-1,318
| -20% | -$37.3K |
|
5085
Blue Bird Corp
BLBD
$2.35B
| $145K | ﹤0.01% |
7,619
-2,142
| -22% | -$40.8K |
|
5086
CALL
Camping World
CWH
$639M
| $144K | ﹤0.01% |
16,200
-2,600
| -14% | -$25.1K |
|
5087
Daily Journal
DJCO
$809M
| $144K | ﹤0.01% |
580
-174
| -23% | -$39.6K |
|
5088
Southern Missouri Bancorp
SMBC
$852M
| $144K | ﹤0.01% |
3,975
-1,239
| -24% | -$41.9K |
|
|
ONIT
5089
Onity Group
ONIT
$309M
| $144K | ﹤0.01% |
5,077
-1,907
| -27% | -$53.3K |
|
|
BPL
5090
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $144K | ﹤0.01% |
3,500
-1,500
| -30% | -$61.9K |
|
5091
CALL
Arista Networks
ANET
$227B
| $143K | ﹤0.01% |
9,600
-9,600
| -50% | -$149K |
|
5092
Colliers International
CIGI
$5.04B
| $143K | ﹤0.01% |
+1,900
| New | +$135K |
|
5093
Cyclerion Therapeutics
CYCN
$14.9M
| $143K | ﹤0.01% |
590
-171
| -22% | -$36.9K |
|
5094
PUT
Healthpeak Properties
DOC
$15.1B
| $143K | ﹤0.01% |
4,000
-2,900
| -42% | -$97.9K |
|
5095
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$150M
| $143K | ﹤0.01% |
2,200
+500
| +29% | +$34.3K |
|
5096
Comscore
SCOR
$106M
| $143K | ﹤0.01% |
3,741
-1,437
| -28% | -$83K |
|
5097
Surgery Partners
SGRY
$2.01B
| $143K | ﹤0.01% |
19,294
+3,432
| +22% | +$24.6K |
|
5098
PUT
Corpay
CPAY
$25B
| $143K | ﹤0.01% |
+500
| New | +$145K |
|
|
SMMF
5099
DELISTED
Summit Financial Group, Inc.
SMMF
| $143K | ﹤0.01% |
5,598
-1,780
| -24% | -$45.9K |
|
|
REV
5100
PUT
DELISTED
Revlon, Inc.
REV
| $143K | ﹤0.01% |
6,100
+4,300
| +239% | +$81.2K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.